 | Issue navigator |
|
|
Contents of Volume 4 Suppl 1
Association for Immunotherapy of Cancer: Cancer Immunotherapy  2nd Annual Meeting Meeting abstracts - A single PDF containing all abstracts in this Supplement is available here.
Mainz, Germany. 6 7 May 2004
|
Oral presentation
Bispecific costimulatory molecules for activation of tumor-killing lymphocytes
R Weth, M Biburger, W Wels
Cancer Cell International 2004, 4(Suppl 1):S1 (1 July 2004)
[Abstract] [Full text] [PDF] [PubMed] [Related articles]
Oral presentation
Antibody-based immunoreceptors: the impact of signalling domain, binding affinity and costimulation
A Hombach, C Heuser, H Abken
Cancer Cell International 2004, 4(Suppl 1):S2 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Tolerability and efficacy of the trifunctional antibody removab® (anti-EpCAM x anti-CD3) in patients with malignant ascites due to ovarian cancer: Results of a phase I/II study
P Wimberger, A Burges, V Gorbounova, H Sommer, B Schmalfeldt, J Pfisterer, M Lichinitser, A Makhson, M Ströhlein, W Eiermann, M Biakhov, V Moiseenko, A du Bois, R Kimmig
Cancer Cell International 2004, 4(Suppl 1):S3 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
HLA DR-directed bispecific single-chain Fv antibodies for lymphoma therapy
Y Wachter, J Brünke, S Schuster, K Barbin, M Peipp, T Valerius, M Gramatzki, G Fey, R Repp
Cancer Cell International 2004, 4(Suppl 1):S4 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Increased frequency of CTLA4+ TGF + CD4+ CD25+ T cells in peripheral blood of patients with chronic lymphatic leukemia and multiple myeloma
M Beyer, M Kochanek, M von Bergwelt-Baildon, A Popov, J Wolf, JL Schultze
Cancer Cell International 2004, 4(Suppl 1):S5 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
MMP-7 inhibits CTL tumor cell interaction
S Gregor, V Alla, J Kuball, M Theobald, PR Galle, D Strand, S Strand
Cancer Cell International 2004, 4(Suppl 1):S6 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Genetically modified natural killer cells specifically recognizing the tumor-associated antigens ErbB2/HER2 and EpCAM
C Uherek, T Müller, T Tonn, B Uherek, H-G Klingemann, WS Wels
Cancer Cell International 2004, 4(Suppl 1):S7 (1 July 2004)
[Abstract] [Full text] [PDF] [1 comment]
Oral presentation
Rapid functional exhaustion and deletion of cytotoxic T lymphocytes following immunization with recombinant adenovirus
E Scandella, P Krebs, B Odermatt, B Ludewig
Cancer Cell International 2004, 4(Suppl 1):S8 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
High frequency of functionally active Melan-A specific T cells in a patient with progressive immunoproteasome-deficient melanoma
N Meidenbauer, A Zippelius, MJ Pittet, M Laumer, S Vogl, J Heymann, M Rehli, B Seliger, S Schwarz, F-A Le Gal, PY Dietrich, R Andreesen, P Romero, A Mackensen
Cancer Cell International 2004, 4(Suppl 1):S9 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Adoptive T cell therapy using antigen-specific CD8+ T cells for the treatment of patients with metastatic melanoma: a phase I clinical study
N Meidenbauer, S Vogl, M Laumer, J Heymann, R Andreesen, A Mackensen
Cancer Cell International 2004, 4(Suppl 1):S10 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Large scale in vitro expansion of polyclonal human CD4+CD25high regulatory T cells
P Hoffmann, R Eder, LA Kunz-Schughart, R Andreesen, M Edinger
Cancer Cell International 2004, 4(Suppl 1):S11 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Reversible HLA multimers (streptamers) for isolation of human cytotoxic T lymphocytes functionally active against tumor- and virus-derived antigens
J Neudorfer, B Schmidt, K Huster, M Schiemann, T Schmidt, H Wagner, C Peschel, DH Busch, H Bernhard
Cancer Cell International 2004, 4(Suppl 1):S12 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Therapeutic efficacy of RAGE-1 and MAGE-9 peptide specific cytotoxic T cell clones in renal cell carcinoma
N Oehlrich, M Linnebacher, S Stevanovic, M Zoeller
Cancer Cell International 2004, 4(Suppl 1):S13 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
The role of glycosylation as a modulator for signalling strength in T cells
B Hauptrock, J Kuball, R-H Voss, M Brkic, C Huber, M Theobald
Cancer Cell International 2004, 4(Suppl 1):S14 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Migration of dendritic cells to regional lymph nodes in a vaccination trial
A Riccobon, R Ridolfi, R Galassi, M Petrini, M Stefanelli, L Fiammenghi, G Giorgetti, A Moretti, L Ridolfi, G Fiorentini
Cancer Cell International 2004, 4(Suppl 1):S15 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Transitory response to vaccination with PSCA-/PSA-peptide loaded, autologous dendritic cells in patients with metastatic, hormone-refractory prostate cancer
AK Kaskel, R Zeiser, R Jochim, W Schultze-Seemann, CF Waller, H Veelken
Cancer Cell International 2004, 4(Suppl 1):S16 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Vaccination with WT1 induces high frequency memory and effector T cells in peripheral blood and bone marrow associated with complete remission of recurrent AML
A Letsch, C Scheibenbogen, AM Asemissen, V Mailänder, E Thiel, U Keilholz
Cancer Cell International 2004, 4(Suppl 1):S17 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers
A Bender, J Karbach, A Neumann, M Biskamp, D Jäger, S Gnjatic, E Hoffman, LJ Old, A Knuth, E Jäger
Cancer Cell International 2004, 4(Suppl 1):S18 (1 July 2004)
[Abstract] [Full text] [PDF]
Oral presentation
Tumor vaccination after allogeneic bone marrow cell reconstitution of the non-myeloablatively conditioned tumor-bearing murine host
M Zöller
Cancer Cell International 2004, 4(Suppl 1):S19 (1 July 2004)
[Abstract] [Full text] [PDF]
Poster presentation
Limiting the risk of immunogenicity by identification and removal of T-cell epitopes (DeImmunisation )
K Hellendoorn, T Jones, J Watkins, M Baker, A Hamilton, F Carr
Cancer Cell International 2004, 4(Suppl 1):S20 (1 July 2004)
[Abstract] [Full text] [PDF]
| |
| 
 |
